Login
Navigate Fool.com
Will AMRS beat
the market?

AMYRIS INC COM

NASDAQ: AMRS

Community Rating: 2 Stars: Unattractive

3.35 0.18 (5.68%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $3.27
Previous Close $3.17
Daily Range $3.12 - $3.36
52-Week Range $2.17 - $6.11
Market Cap $257.3M
P/E Ratio -1.02
Dividend (Yield) $0.00 (0.0%)
Volume 319,215
Average Daily Volume 810,521
Current FY EPS -$1.52

How do you think AMRS
will perform against the market?

Top AMRS Bull/Bear Pitches

 

handyman77 (< 20)
Submitted January 11, 2011

Amysis is a renewable products company that is applying its industrial synthetic biology platform to be used for speciality chemicals and transportation fuels. Speciality chemicals includes industria … More

0 Replies Reply Report this Post
 

EclecticRecluse (< 20)
Submitted January 30, 2011

Weakening Earnings Opinion

0 Replies Reply Report this Post

News & Commentary

The World's Leading Tire Manufacturers Are Turning to Synthetic Biology -- But Not for the Reason Yo

Forget sustainability -- 13 of the world's leading tire manufacturers are eyeing Amyris' synthetic biology platform for a completely different reason.

Rising World Food Prices Spell Trouble for Biofuels

As crop prices rise, biofuel producer margins fall. Some of these companies are more at risk than others.

Why Shares of Amyris Inc Popped Today

Is this meaningful or just another movement?

Clean Energy Investment Is Falling, but That's Good News -- for Solar Stocks

The world spent less on clean energy in 2013 than it spent in 2012, and less in 2012 than it spent in 2011. That's only cause for concern if you aren't buying the right clean energy stocks.

Mid-Afternoon Market Update: Markets Drop Sharply During Janet Yellen's First Conference

Biofuels Trying to Hit Big Oil Where It Hurts

Biofuel companies will struggle to match the sheer volume and production costs realized by Big Oil companies, but they can challenge Big Oil in the production of specialty chemicals.

KiOR Earnings Not Worth the Wait

KiOR delayed reporting its financials as long as possible. When the filing was finally made, big operational and technological troubles were revealed.

Can Amyris Inc. Save Deep-Sea Sharks and Expand This Market by 230%?

Many personal care products you use on a daily basis manufactured by Avon, Unilever, and Procter & Gamble use a rare ingredient called squalane. Unfortunately, about 40% of the global supply comes from deep-sea shark catches. Luckily, Amyris has a solution.

How Designer Microbes and the Organism Industry Will Reshape Our World

Many investors are captivated by the future of companies such as Tesla Motors and 3-D Systems -- and the potential creation of shareholder value on a scale that will be difficult to match. But are investors overlooking an even more promising industry with a brighter future?

Solazyme Follows Amyris Results With Impressive Developments of Its Own

Renewable oils manufacturer Solazyme is up today on positive developments from 2013 and early operations thus far in 2014. Here's what you need to know.

See More AMRS News...

Sector

Healthcare

Industry

Drugs

AMYRIS INC COM (AMRS) Description

Amyris Inc. is building a renewable products company by applying its industrial synthetic biology technology platform to provide alternatives to select petroleum-sourced products used in specialty chemical and transportation fuel markets worldwide. Website: http://www.amyris.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks